Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-1,066 Cr₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr₹-1,506 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-1,066 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-1,066 Cr
Mar2024₹-1,049 Cr
Mar2023₹-1,805 Cr
Mar2022₹-1,655 Cr
Mar2021₹-1,506 Cr

How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-1,066 Cr
Negative
Mar2024 ₹-1,049 Cr
Negative
Mar2023 ₹-1,805 Cr
Negative
Mar2022 ₹-1,655 Cr
Negative
Mar2021 ₹-1,506 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,614.6 Cr -1% -3.7% 32.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,210.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 5.9% -3.7% -6.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1%

-3.7%

32.7%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses